stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / MRK / Revenue

Merck & Co., Inc. Revenue 2007–2025

Merck & Co., Inc. (MRK) annual revenue by fiscal year, computed from SEC filings. Compound growth +5.6%/yr over 18 years.

Fiscal yearRevenueChange (YoY)
FY 2025$65.01B+1.3%
FY 2024$64.17B+6.7%
FY 2023$60.12B+1.4%
FY 2022$59.28B+21.7%
FY 2021$48.70B+17.3%
FY 2020$41.52B+6.1%
FY 2019$39.12B-7.5%
FY 2018$42.29B+5.4%
FY 2017$40.12B+0.8%
FY 2016$39.81B
FY 2015$0
FY 2014$0
FY 2013$0
FY 2012$0
FY 2011$0-100.0%
FY 2010$45.99B+67.7%
FY 2009$27.43B+15.0%
FY 2008$23.85B-1.4%
FY 2007$24.20B

Source: Merck & Co., Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Merck & Co., Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Merck & Co., Inc. — frequently asked questions

What is Merck & Co., Inc.'s revenue?

Merck & Co., Inc. (MRK) reported revenue of $65.01B for fiscal year 2025, per its SEC filings.

How has Merck & Co., Inc.'s revenue changed over time?

Between fiscal 2007 and 2025, MRK's revenue grew at roughly 5.6% per year (compound annual rate), from $24.20B to $65.01B.

Where does this data come from?

Figures are computed from Merck & Co., Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More MRK financial history

Full MRK fundamentals page → · All 1,500+ companies →